Published in Hepatitis Weekly, September 4th, 2006
"Many patients with chronic hepatitis C virus (HCV) have persistently normal serum ALT levels. We compared characteristics of chronic hepatitis C patients with patients with normal and elevated ALT levels using data from 3 randomized phase III trials of peginterferon alfa-2a (40 kDa)," wrote M.L. Shiffman and colleagues, Virginia Commonwealth University.
They continued, "The characteristics of 480...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.